O
AGEN

OrbiMed’s Agenus AGEN Stock Holding History

OrbiMed’s Portfolio AGEN Stock Details AGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-124,394
Closed -$9.69M – 136
2014
Q4 		$9.69M Sell
124,394
-58,318
-32% -$3.59M 0.09% 94
2014
Q3 		$11.2M Hold
182,712
– – 0.12% 94
2014
Q2 		$11.5M Sell
182,712
-74,586
-29% -$4.32M 0.14% 77
2014
Q1 		$16M Buy
+257,298
New +$17.9M 0.2% 70

Other funds holding AGEN

QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

OrbiMed's AGEN Position: Q1 2015 in Review

OrbiMed sold out of Agenus (AGEN) in Q1 2015, closing a stake of 124,394 shares — an estimated $9.69M sold.

OrbiMed first reported a position in AGEN in Q1 2014 and held it in 4 quarters. The position peaked at $16M in Q1 2014. 84 funds tracked by Wall St. Rank hold AGEN as of Q1 2015.

  • OrbiMed reported no remaining Agenus position as of Q1 2015 after selling out during the quarter.
  • OrbiMed sold 124,394 Agenus shares in Q1 2015, an estimated $9.69M.
  • OrbiMed first reported a position in Agenus in Q1 2014 and held it in 4 quarters.
  • OrbiMed's Agenus position peaked at $16M in Q1 2014.
  • 84 funds tracked by Wall St. Rank held Agenus as of Q1 2015.

Based on OrbiMed's 13F filing for Q1 2015, filed 15 May 2015.